Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8101–8150 of 18654
John Young, the Company's current Vice President of Finance, has been elected to succeed Mr. White as Chief Financial Officer effective as of February 1, 2024.
On October 17, 2023, Matthew S. Stadler provided notice to the Company of his intention to retire from his positions as Executive Vice President and Chief Financial Officer of the Company, after nearly 19 years of service to the Company and a 43 year career in the financial services industry.
Mr. Knutson will thereafter hold the position of President and Chief Executive Officer.
On October 16, 2023, Gaylon Morris submitted to the Board of Directors (the "Board") of Sunworks, Inc. (the "Company") his resignation from his position as Chief Executive Officer and director of the Company, effective October 16, 2023.
Effective October 16, 2023, the remaining Board appointed Mark Trout, age 59, who was the Group CEO of Solcius, the Company’s wholly owned residential solar business, as the Company’s Chief Executive Officer and as a member of the Board.
On October 18, 2023, the Company announced the appointment of Ethan Rudin to serve as the Chief Financial Officer of the Company, effective immediately.
The Board has appointed Simon Meester, the current President Aerial Work Platforms, to succeed Mr. Garrison as President and CEO, effective January 1, 2024.
John L. Garrison Jr. notified the Board of Directors (the “Board”) of Terex Corporation (“Terex” or the “Company”) of his intention to retire as Chairman, CEO and as a member of the Board, effective January 1, 2024.
appointed Laurie Ann Goldman as President and Chief Executive Officer, effective October 17, 2023
the Board terminated the employment of Miguel Fernandez as the Company's President and Chief Executive Officer
On October 11, 2023, Scott Huckins notified the Company that he is resigning from his position as Chief Financial Officer and General Manager of Fruit-Based Foods and Beverages of the Company effective October 13, 2023, in order to accept a position with another public company.
Upon Mr. Huckins' departure, Greg Gaba was promoted to the role of Chief Financial Officer of the Company effective October 13, 2023.
the board of directors (the “Board”) of Kubient, Inc. (the “Company”) appointed Elisabeth DeMarse as Interim Chief Executive Officer of the Company.
As previously announced, Michael Turner resigned as the Company’s Executive Vice President and Chief Financial Officer, effective October 15, 2023.
Lauri Kearnes departing the Company as of October 13, 2023
appointing David Garrison as the Interim CFO, effective as of October 23, 2023
On October 12, 2023, Ilan Daskal, the Executive Vice-President, Chief Financial Officer of Bio-Rad Laboratories, Inc. (the “Company”) and the Company’s principal financial officer, notified the Company of his plans to resign from the Company to pursue another opportunity, effective at the close of business on November 6, 2023.
Siobhan Nolan Mangini who, as previously announced by the Company, is stepping down as President and Chief Financial Officer on December 1, 2023.
Raymond E. Reitsma will be appointed to those positions effective June 1, 2024.
Robert B. Kaminski, Jr. intends to retire as President and Chief Executive Officer of Mercantile and Raymond E. Reitsma will be appointed to those positions effective June 1, 2024.
On October 16, 2023, the Company and Michael L. Peterson entered into an employment agreement (the “Peterson Employment Agreement”), effective as of October 23, 2023 (the “Peterson Employment Agreement Effective Date”), pursuant to which Mr. Peterson will serve as Chief Executive Officer of the Company, replacing Mr. Ingriselli.
On October 6, 2023, Frank C. Ingriselli delivered to the Board of Directors (“Board”) of Trio Petroleum Corp. (the “Company”) a notice of his resignation as the Company’s Chief Executive Officer, effective on October 23, 2023 (the “Resignation Effective Date”).
On October 11, 2023, in connection with a management restructuring, Greenidge Generation Holdings Inc. (the “Company”) appointed Christian Mulvihill as its new Chief Financial Officer (“CFO”), succeeding Robert Loughran, who no longer remains with the Company.
On October 11, 2023, in connection with a management restructuring, Greenidge Generation Holdings Inc. (the “Company”) appointed Christian Mulvihill as its new Chief Financial Officer (“CFO”), succeeding Robert Loughran, who no longer remains with the Company.
appointed Geoffrey Parker as the Company’s Executive Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer effective October 16, 2023
replacing David M. Chang, M.D., Ph.D. and Jack Chen in their capacities as the Company’s interim principal financial officer and interim principal accounting officer, respectively.
On October 16, 2023, the Board of Directors of the Company appointed Theresa Neri Strong to serve as the Company’s interim Chief Financial Officer effective upon Mr. Walker’s departure.
Mr. Menzo Case, President and Chief Executive Officer of the Company and the Bank, passed away on October 13, 2023.
The Company announced that effective October 16, 2023, Angela Krezmer, the Company’s Chief Financial Officer, has been appointed to serve as the Company’s interim Principal Executive Officer.
Effective October 13, 2023, Shawn M. Guertin, the Executive Vice President and Chief Financial Officer of CVS Health Corporation (“CVS Health,” the “Company,” “we” or “our”), has begun a personal leave of absence for unforeseen family medical reasons.
Appointment of Interim Chief Financial Officer In connection with Mr. Guertin’s leave, the Company’s Board of Directors appointed Thomas F. Cowhey, Senior Vice President, Corporate Finance, to serve as the Company’s Interim Chief Financial Officer, effective October 13, 2023.
On October 10, 2023, the Board of Directors (the “Board”) of Meta Materials Inc. (also referred to herein as the “Company”, “we”, “us”, or “our”) removed George Palikaras as President and Chief Executive Officer (“CEO”) of the Company, effective immediately.
the Board appointed Jim Fusaro as the new CEO of the Company, effective immediately.
the Company notified Ran Daniel, its Chief Financial Officer since 2018, that the Employment Agreement would not be renewed.
On October 11, 2023, the Board of Directors of the Company, based upon the recommendation of its Audit Committee, appointed Shlomo Zakai as the Company’s Chief Financial Officer.
On October 10, 2023, the Board of Directors (the “Board”) of WeWork Inc. (the “Company”) appointed David Tolley as the Company’s Chief Executive Officer (“CEO”) on a permanent basis.
On October 16, 2023, DBV Technologies S.A. (the “Company”) announced the appointment of Virginie Boucinha as the Company’s Chief Financial Officer and principal accounting officer, effective as of November 6, 2023.
In addition, the Company announced that Sébastien Robitaille, who currently serves as the Company’s Chief Financial Officer, will separate employment with the Company effective November 17, 2023 to pursue other opportunities.
Upon such resignations, Ebru Törehan was appointed as Chief Executive Officer, Chairman of the Board, Treasurer and Secretary, and Director of the Company.
On October 12, 2023, the board of directors of the Bionexus Gene Lab Corp. (“the Company”) approved the appointment of Mr. Chi Yuen Leong as the Chief Executive Officer and a director, effective October 12, 2023.
On October 10, 2023, Greg Powell submitted his resignation as Chief Financial Officer of Midwest Energy Emissions Corp. (the “Company”) effective immediately.
the Company appointed Benjamin L. Stilwill as Chief Executive Officer of the Company, effective October 13, 2023.
the Company appointed Bryant “B.J.” Reeves as Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer of the Company, effective October 13, 2023.
Thomas J. Gibson will no longer serve as Chief Financial Officer of the Company, effective October 13, 2023.
On October 16, 2023, Mr. Pak Hong WAN (“Mr. WAN”) resigned his positions as Chief Executive Officer, Chief Financial Officer, President, Treasurer and Secretary and the Chairman of Board of Directors of the Company.
On October 16, 2023, the Company’s Board of Directors appointed Mr. Hoi Sau KOO (“Mr. KOO”), aged 25, to act as the Chief Executive Officer, Chief Financial Officer, President, Treasurer, Secretary and the Chairman of Board of Directors of the Company.
In addition to his resignation from the Company's Board of Directors, Mr. Morales tendered his resignation as the Company's President and Chief Executive Officer effective on October 13, 2023
The Board of Directors of Allogene Therapeutics, Inc. (the “Company”) appointed Geoffrey Parker as the Company’s Executive Vice President, Chief Financial Officer, Principal Financial Officer, and Principal Accounting Officer effective October 16, 2023.
Tanya Andreev-Kaspin, who has been with the Company since August 22, 2012, and has served as the Company’s CFO since January 1, 2020, will be leaving Innovid to pursue other opportunities.
On October 16, 2023, Innovid announced the appointment of Anthony Callini as the Company’s new Chief Financial Officer (the “CFO”), effective October 16, 2023.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.